We are a diversified healthcare company with the scale, capabilities, and resources required to efficiently undertake the design, development, and commercialization of new medical device technologies, but we still maintain our entrepreneurial and nimble culture which allows us to respond quickly to new market and product opportunities.
Brookhaven Medical (BMI) is dedicated to improving patient outcomes by designing and developing innovative medical devices that address unmet clinical needs in the vascular and urology markets.
We are a leading OEM in the United States for developing and manufacturing new high value-added proprietary medical devices. Our company is growing rapidly by meeting significant patient needs.
Brookhaven Medical has a proven track record of solving problems and successfully creating new medical devices faster and less expensively than our competitors or the internal resources of our OEM customers.
Brookhaven Medical enables physicians, entrepreneurs and other medical device companies to work closely with our product development teams. Through this close collaboration, their collective ideas become important new medical devices that address unmet needs and improve clinical outcomes.
JOHN D. FELTMAN
, CHAIRMAN & CEO
Mr. Feltman has been Chairman and CEO of Brookhaven Capital Corporation since 1996. Mr. Feltman has been an active investor, financier, and entrepreneur in medical devices since 1996 has been responsible for raising more than $100 million in capital for four medical device companies (Brookhaven, FutureMatrix, CeloNova Biosciences, and Ascendx Spine). Mr. Feltman founded and served as Chairman and CEO of the predecessor to CeloNova in 2000 until selling a controlling interest in late 2003. FULL BIO
As founder and Chairman of Ascendx Spine, he led an IPO on the AIM Market of the London Stock Exchange in 2007 and later served as CEO after taking Ascendx private again. Mr. Feltman has also been an advisor to many early stage medical device companies. Mr. Feltman began his career in 1982 at J.C. Bradford & Co., where he was a First Vice-President. He later held senior positions in Atlanta at Interstate/Johnson Lane, Bear Stearns, and was a Managing Director of investment banking in New York with Commonwealth Associates. Mr. Feltman served as a director of FutureMatrix since early 2000 until the merger with the Company. Mr. Feltman was educated at the University of Georgia.
, CHIEF FINANCIAL OFFICER
Mr. Morin has over 16 years of experience as a finance and operational executive with global manufacturing companies. Prior to joining Brookhaven Medical, Inc., Mr. Morin was the Global Controller of EndoChoice Holdings (NYSE:GI) and helped take the company public in June 2015. FULL BIO
During his tenure at EndoChoice, Mr. Morin oversaw all aspects of the finance, accounting, treasury and tax functions and helped the Company raise over $200 million in debt and equity financing, including over $100 million in its IPO. His previous positions included Director of Finance at EndoChoice and Vice President of Finance and Accounting at Case-Mate, Inc. Prior to that, Mr. Morin worked in public accounting with KPMG. He has an MBA from Emory University, a masters of accounting degree from Georgia State University and a bachelor’s of accounting degree from St. Michaels’ College. He is also a licensed CPA in the state of Georgia.
ROBERT E. ALTENBACH
, SECRETARY, GENERAL COUNSEL
Mr. Altenbach serves as General Counsel and Corporate Secretary of the company. Previously, Mr. Altenbach served as President, General Counsel, and a member of the Board of Directors of Senior Care Group, a non-profit corporation that owns and operates skilled nursing homes and assisted living care facilities in five states. FULL BIO
Mr. Altenbach has more than 40 years of experience in the practice of law and was a principal shareholder and later Of Counsel to the international law firm of Greenberg Traurig, LLP. He holds a BS in Business and a JD from the University of Tennessee. Mr. Altenbach is an active member of State Bar of Georgia and the Tennessee Bar Association.